Study spotlights rapid LAMP testing for canine Dirofilaria
Bottom line
Version 1 — Brief
Researchers have reported two new species-specific, direct closed-tube LAMP assays designed to detect Dirofilaria immitis and Dirofilaria repens directly from canine whole blood, without a separate DNA extraction step. The study, published in Animals by Zsófia Bujtor, Tünde Földvári, and Csaba Pribenszky, positions the assays as a rapid, point-of-care molecular option for distinguishing the heartworm agent D. immitis from D. repens, a filarial parasite of growing veterinary and zoonotic concern in Europe and other endemic regions. The work arrives as interest grows in faster molecular diagnostics that can complement microscopy, antigen testing, and lab-based PCR for canine dirofilariasis. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, the main value is species-level detection at or near the point of care. Current guidance still emphasizes annual antigen testing plus microfilaria testing for dogs, because discordant results do occur, including antigen-negative, microfilaria-positive cases and occult infections. A rapid molecular assay that can differentiate D. immitis from D. repens could be especially useful in endemic settings, referral workups, surveillance programs, and cases where microscopy expertise or full PCR access is limited. It’s also relevant because D. repens carries zoonotic importance, and molecular methods may help clarify infections that are harder to sort out with morphology alone. (heartwormsociety.org)
What to watch: The next question is whether these assays move beyond proof-of-concept into broader clinical validation, commercial development, and comparison against routine in-clinic heartworm workflows. (sciencedirect.com)
Key facts
- Study type
- Two species-specific, direct closed-tube LAMP assays
- Target organisms
- Dirofilaria immitis and Dirofilaria repens
- Sample type
- Canine whole blood
- DNA extraction
- Not required
- Purpose
- Species-level molecular detection at or near the point of care
- Journal
- Animals
- Clinical context
- Canine dirofilariasis
- Diagnostic gap
- Designed to help distinguish heartworm infection from D. repens in endemic settings
Version 2 — Full analysis
A new Animals study describes two direct closed-tube LAMP assays for rapid detection of Dirofilaria immitis and Dirofilaria repens in canine blood, aiming to bring species-specific molecular testing closer to the point of care. The report matters because canine dirofilariasis is no longer just a reference-lab problem: clinicians increasingly need fast ways to distinguish heartworm-associated infection from other filarial infections, particularly in regions where both parasites circulate and where zoonotic risk is part of the clinical and public health picture. (journals.asm.org)
The backdrop is a diagnostic landscape that still depends heavily on antigen tests, microfilaria detection, and conventional PCR. The American Heartworm Society says dogs should be tested with both antigen and microfilaria methods, reflecting the fact that neither approach is perfect on its own. Antigen-negative, microfilaria-positive cases can occur, and antigen-positive, microfilaria-negative occult infections are also well recognized. Meanwhile, D. repens adds another layer of complexity in countries where it is endemic, because species differentiation may be difficult with routine microscopy and because the parasite has clear zoonotic relevance. (heartwormsociety.org)
According to the study summary, the new assays were built as species-specific LAMP tests that work directly from canine whole blood in a closed-tube format, a design choice meant to reduce contamination risk and simplify workflow compared with multi-step molecular methods. That matters operationally: LAMP is already viewed as a practical alternative to PCR because it runs under isothermal conditions and can support faster, simpler detection. Prior work has shown LAMP’s promise for Dirofilaria diagnostics, including an earlier assay for D. repens, but most molecular approaches in this space still rely on extraction steps, specialized instrumentation, or centralized lab capacity. (pubmed.ncbi.nlm.nih.gov)
The broader field is moving in the same direction. Auburn University’s molecular diagnostics service already offers PCR detection for D. immitis and D. repens, underscoring real clinical demand for species-level molecular confirmation. A 2026 Parasites & Vectors study also evaluated a separate point-of-care molecular platform, the Pluslife Mini Dock duplex assay, against the modified Knott’s test and found high overall agreement, with the molecular test identifying slightly more D. immitis-positive samples. Taken together, those developments suggest a wider push toward faster filarial diagnostics that are more usable in practice settings, not just research labs. (vetmed.auburn.edu)
Outside commentary specific to this paper appears limited so far, but expert guidance and recent reviews support the study’s premise. Reviews of heartworm diagnostics note that LAMP, HRM-qPCR, ddPCR, and related methods are attracting attention because they may improve sensitivity, enable earlier or clearer detection, and help resolve cases that don’t fit neatly into standard antigen-test algorithms. At the same time, systematic review evidence on current point-of-care heartworm tests shows that diagnostic performance varies, which is why new assays will need careful head-to-head validation before clinicians can rely on them in routine decision-making. (mdpi.com)
Why it matters: For veterinary teams, this is less about replacing today’s heartworm testing recommendations and more about adding another tool where current methods leave gaps. In general practice, annual antigen and microfilaria testing will remain foundational. But in endemic or emerging areas, shelter medicine, imported-dog screening, epidemiologic surveillance, and cases with discordant results, a rapid species-specific molecular assay could improve confidence and speed. That’s especially true where D. repens is in the differential, since its detection has implications not only for canine management, but also for zoonotic surveillance and client communication with pet parents. (heartwormsociety.org)
There’s also a workflow angle. A direct closed-tube assay, if it proves robust outside the research setting, could lower barriers tied to sample prep, contamination control, and turnaround time. That could make molecular confirmation more realistic in clinics or regional diagnostic settings that don’t have full PCR infrastructure. Still, clinicians will want to know the practical details that determine adoption: sensitivity in low-burden infections, performance against occult cases, cross-reactivity with other filarioids, cost per test, instrument requirements, and how results compare with standard antigen testing, modified Knott’s testing, and reference-lab PCR. (heartwormsociety.org)
What to watch: Watch for full-text performance data, external validation in larger and more geographically diverse canine populations, and any move toward commercialization or incorporation into broader heartworm and filarial testing workflows. (researchgate.net)